Paul Barr, MD of University of Rochester, discusses data from the Resonate-2 Study at the 58th ASH Annual Meeting in San Diego, CA.
Data from Resonate- 2 Study Highlights Ibrutinib Performance in 11q deletion disorder
Paul Barr, MD of University of Rochester, discusses data from the Resonate-2 Study at the 58th ASH Annual Meeting in San Diego, CA.